Association of Gestational Cardiovascular Health With Pregnancy Outcomes
Recruiting now
Conditions studied: Pregnant Women
In brief
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
Key facts
- Study ID
- NCT05776082
- Run by
- Women's Hospital School Of Medicine Zhejiang University
- People needed
- 5000
- Starts
- 2023-03-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2025-12-29
Who can join
Age: 20 and older, up to 49. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Maternal age: 20-49 years;
- Natural conception;
- Single pregnancy;
- Plan to have routine prenatal examinations and give birth in the research center;
You may not qualify if…
- Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;
- Assisted reproduction;
- Multiple pregnancy;
- Fetus has a known deformity or genetic defects;
- Incomplete clinical data.
Where it is running
- Women's Hospital School Of Medicine Zhejiang University — Hangzhou, Zhejiang, China (enrolling)
- Taizhou First People's Hospital — Taizhou, Zhejiang, China (enrolling)
- Rwanda Society of Obstetricians and Gynecologists — Kigali, Rwanda
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.